Amalgamated Bank’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $14.9M | Sell |
38,513
-1,934
| -5% | -$717K | 0.1% | 137 |
|
|
2026
Q1 | $11.8M | Sell |
40,447
-1,756
| -4% | -$577K | 0.09% | 179 |
|
|
2025
Q4 | $14.8M | Sell |
42,203
-557
| -1% | -$188K | 0.11% | 139 |
|
|
2025
Q3 | $13.8M | Sell |
42,760
-853
| -2% | -$265K | 0.1% | 157 |
|
|
2025
Q2 | $17M | Sell |
43,613
-2,310
| -5% | -$929K | 0.13% | 130 |
|
|
2025
Q1 | $20M | Buy |
45,923
+680
| +2% | +$273K | 0.17% | 97 |
|
|
2024
Q4 | $16.7M | Sell |
45,243
-2,750
| -6% | -$1.15M | 0.14% | 115 |
|
|
2024
Q3 | $25M | Buy |
47,993
+623
| +1% | +$333K | 0.21% | 75 |
|
|
2024
Q2 | $25.7M | Sell |
47,370
-1,681
| -3% | -$889K | 0.22% | 72 |
|
|
2024
Q1 | $25.4M | Sell |
49,051
-8,527
| -15% | -$4.24M | 0.22% | 74 |
|
|
2023
Q4 | $27.2M | Sell |
57,578
-2,997
| -5% | -$1.39M | 0.22% | 76 |
|
|
2023
Q3 | $26.4M | Sell |
60,575
-2,000
| -3% | -$907K | 0.22% | 76 |
|
|
2023
Q2 | $27.8M | Sell |
62,575
-2,130
| -3% | -$983K | 0.23% | 76 |
|
|
2023
Q1 | $29.8M | Buy |
64,705
+1,139
| +2% | +$542K | 0.25% | 69 |
|
|
2022
Q4 | $32.6M | Sell |
63,566
-915
| -1% | -$465K | 0.29% | 61 |
|
|
2022
Q3 | $29.3M | Buy |
64,481
+1,365
| +2% | +$653K | 0.28% | 56 |
|
|
2022
Q2 | $30.5M | Sell |
63,116
-1,982
| -3% | -$981K | 0.28% | 59 |
|
|
2022
Q1 | $32M | Sell |
65,098
-4,347
| -6% | -$1.99M | 0.25% | 64 |
|
|
2021
Q4 | $32.2M | Buy |
69,445
+2,299
| +3% | +$967K | 0.24% | 74 |
|
|
2021
Q3 | $25M | Sell |
67,146
-2,595
| -4% | -$986K | 0.21% | 79 |
|
|
2021
Q2 | $26.6M | Buy |
69,741
+55,726
| +398% | +$21.3M | 0.21% | 77 |
|
|
2021
Q1 | $5.03M | Sell |
14,015
-589
| -4% | -$189K | 0.19% | 85 |
|
|
2020
Q4 | $4.69M | Sell |
14,604
-244
| -2% | -$74.9K | 0.18% | 88 |
|
|
2020
Q3 | $3.99M | Sell |
14,848
-362
| -2% | -$97.4K | 0.17% | 91 |
|
|
2020
Q2 | $4M | Sell |
15,210
-23,152
| -60% | -$6.18M | 0.19% | 88 |
|
|
2020
Q1 | $8.71M | Sell |
38,362
-1,355
| -3% | -$369K | 0.21% | 94 |
|
|
2019
Q4 | $12M | Buy |
39,717
+1,448
| +4% | +$398K | 0.22% | 82 |
|
|
2019
Q3 | $9.19M | Buy |
38,269
+2,122
| +6% | +$581K | 0.19% | 95 |
|
|
2019
Q2 | $10.2M | Buy |
36,147
+2,975
| +9% | +$813K | 0.24% | 76 |
|
|
2019
Q1 | $9.52M | Buy |
33,172
+1,107
| +3% | +$320K | 0.23% | 81 |
|
|
2018
Q4 | $8.42M | Sell |
32,065
-706
| -2% | -$194K | 0.24% | 77 |
|
|
2018
Q3 | $8.98M | Sell |
32,771
-137
| -0.4% | -$35.6K | 0.22% | 86 |
|
|
2018
Q2 | $7.83M | Buy |
32,908
+922
| +3% | +$214K | 0.19% | 96 |
|
|
2018
Q1 | $7.03M | Sell |
31,986
-414
| -1% | -$97.3K | 0.19% | 106 |
|
|
2017
Q4 | $7.29M | Buy |
32,400
+1,977
| +6% | +$421K | 0.2% | 93 |
|
|
2017
Q3 | $5.78M | Buy |
30,423
+686
| +2% | +$131K | 0.18% | 106 |
|
|
2017
Q2 | $5.59M | Buy |
29,737
+10,831
| +57% | +$1.95M | 0.18% | 105 |
|
|
2017
Q1 | $3.13M | Sell |
18,906
-1,561
| -8% | -$248K | 0.16% | 116 |
|
|
2016
Q4 | $2.94M | Buy |
20,467
+5,007
| +32% | +$670K | 0.13% | 146 |
|
|
2016
Q3 | $1.94M | Buy |
15,460
+90
| +0.6% | +$11.6K | 0.11% | 167 |
|
|
2016
Q2 | $1.97M | Buy |
15,370
+5,757
| +60% | +$788K | 0.11% | 165 |
|
|
2016
Q1 | $1.34M | Buy |
9,613
+2,502
| +35% | +$334K | 0.13% | 132 |
|
|
2015
Q4 | $992K | Sell |
7,111
-2,209
| -24% | -$304K | 0.12% | 154 |
|
|
2015
Q3 | $1.3M | Buy |
9,320
+261
| +3% | +$39.2K | 0.14% | 125 |
|
|
2015
Q2 | $1.49M | Buy |
9,059
+237
| +3% | +$37.9K | 0.15% | 109 |
|
|
2015
Q1 | $1.36M | Buy |
8,822
+2,198
| +33% | +$313K | 0.17% | 117 |
|
|
2014
Q4 | $832K | Sell |
6,624
-1,074
| -14% | -$133K | 0.13% | 167 |
|
|
2014
Q3 | $921K | Buy |
7,698
+13
| +0.2% | +$1.49K | 0.14% | 146 |
|
|
2014
Q2 | $827K | Buy |
7,685
+815
| +12% | +$84K | 0.12% | 170 |
|
|
2014
Q1 | $684K | Sell |
6,870
-566
| -8% | -$51.2K | 0.12% | 207 |
|
|
2013
Q4 | $687K | Buy |
+7,436
| New | +$661K | 0.12% | 190 |
|
Other funds holding ELV
AACR
Amalgamated Bank's ELV Position: Q2 2026 in Review
Amalgamated Bank reduced its Elevance Health (ELV) stake by 4.8% in Q2 2026, selling an estimated $717K and leaving 38,513 shares worth $14.9M. The position accounts for 0.1% of the portfolio, ranked #137.
Amalgamated Bank first reported a position in ELV in Q4 2013 and has held it in 51 quarters since. The position peaked at $32.6M in Q4 2022. 917 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Amalgamated Bank held 38,513 shares of Elevance Health worth $14.9M as of Q2 2026.
- Amalgamated Bank sold 1,934 Elevance Health shares in Q2 2026, an estimated $717K.
- Elevance Health made up 0.1% of Amalgamated Bank's portfolio in Q2 2026, its #137 holding.
- Amalgamated Bank first reported a position in Elevance Health in Q4 2013 and has held it in 51 quarters since.
- Amalgamated Bank's Elevance Health position peaked at $32.6M in Q4 2022.
- 917 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.